The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: A double dissociation between dopamine D2 and 5-HT2A/2C receptors

Pharmacology Biochemistry and Behavior

Volumn 93, Issue 4, 2009, Pages 433-442

  Zhao, Changjiu ^a   Li, Ming ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

5 HT2A 2C receptor; Clozapine; DOI; Dopamine D2 D3 receptor; Haloperidol; Quinpirole; Rat maternal behavior

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; QUINPIROLE; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C RECEPTOR; SODIUM CHLORIDE; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; MATERNAL BEHAVIOR; NESTING; NONHUMAN; PRIORITY JOURNAL; PUERPERIUM; RAT; RECEPTOR BLOCKING;

AMPHETAMINES; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HALOPERIDOL; MATERNAL BEHAVIOR; NESTING BEHAVIOR; POSTPARTUM PERIOD; PREGNANCY; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, DOPAMINE D2; SEROTONIN RECEPTOR AGONISTS;

RATTUS;

EID: 67849133187     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.06.005     Document Type: Article

References (83)

1. Alex K.D., and Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113 (2007) 296-320
2. Baldessarini R.J., Huston-Lyons D., Campbell A., Marsh E., and Cohen B.M. Do central antiadrenergic actions contribute to the atypical properties of clozapine?. Br J Psychiatr Suppl 17 (1992) 12-16
3. Bowers B.J., Henry M.B., Thielen R.J., and McBride W.J. Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat. J Neurochem 75 (2000) 1625-1633
4. Brunner D., Buhot M.C., Hen R., and Hofer M. Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice. Behav Neurosci 113 (1999) 587-601
5. Bubar M.J., and Cunningham K.A. Distribution of serotonin 5-HT2C receptors in the ventral tegmental area. Neuroscience 146 (2007) 286-297
6. Bubar M.J., Seitz P.K., Thomas M.L., and Cunningham K.A. Validation of a selective serotonin 5-HT(2C) receptor antibody for utilization in fluorescence immunohistochemistry studies. Brain Res 1063 (2005) 105-113
7. Burke M., and Sebastian C.S. Treatment of clozapine sedation. Am J Psychiatry 150 (1993) 1900-1901
8. Byrnes E.M., Rigero B.A., and Bridges R.S. Dopamine antagonists during parturition disrupt maternal care and the retention of maternal behavior in rats. Pharmacol Biochem Behav 73 (2002) 869-875
9. Chesler E.J., and Salamone J.D. Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements. Pharmacol Biochem Behav 54 (1996) 619-624
10. Clemett D.A., Punhani T., Duxon M.S., Blackburn T.P., and Fone K.C. Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology 39 (2000) 123-132
11. Cornea-Hébert V., Riad M., Wu C., Singh S.K., and Descarries L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 409 (1999) 187-209
12. De Almeida R.M., and Lucion A.B. Effects of intracerebroventricular administration of 5-HT receptor agonists on the maternal aggression of rats. Eur J Pharmacol 264 (1994) 445-448
13. De Almeida R.M., Giovenardi M., da Silva S.P., de Oliveira V.P., and Stein D.J. Maternal aggression in Wistar rats: effect of 5-HT2A/2C receptor agonist and antagonist microinjected into the dorsal periaqueductal gray matter and medial septum. Braz J Med Biol Res 38 (2005) 597-602
14. De Almeida R.M., Giovenardi M., da Silva S.P., de Oliveira V.P., and Stein D.J. The effect of 5-HT(2a/2c) receptor agonist microinjected into central amygdaloid nucleus and median preoptic area on maternal aggressive behavior in rats. Rev Bras Psiquiatr 28 (2006) 130-134
15. De Almeida R.M., Rosa M.M., Santos D.M., Saft D.M., Benini Q., and Miczek K.A. 5-HT(1B) receptors, ventral orbitofrontal cortex, and aggressive behavior in mice. Psychopharmacology (Berl) 185 (2006) 441-450
16. Deutch A.Y., and Duman R.S. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Neuroscience 70 (1996) 377-389
17. Di Matteo V., De Blasi A., Di Giulio C., and Esposito E. Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol Sci 22 (2001) 229-232
18. Doherty M.D., and Pickel V.M. Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area. Brain Res 864 (2000) 176-185
19. Dollinger M.J., Holloway W.R., and Denenberg V.H. Parturition in the rat (Rattus norvegicus): normative aspects and the temporal patterning of behaviours. Behav Processes 5 (1980) 21-37
20. Dragunow M., Robertson G.S., Faull R.L., Robertson H.A., and Jansen K. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37 (1990) 287-294
21. Eberle-Wang K., Mikeladze Z., Uryu K., and Chesselet M.F. Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 384 (1997) 233-247
22. Ellenbroek B.A., Artz M.T., and Cools A.R. The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine. Eur J Pharmacol 196 (1991) 103-108
23. Fleming A.S., and Corter C. Factors influencing maternal responsiveness in humans: usefulness of an animal model. Psychoneuroendocrinology 13 (1988) 189-212
24. Galef Jr. B.G. Development of olfactory control of feeding-site selection in rat pups. J Comp Physiol Psychol 95 (1981) 615-622
25. Giordano A.L., Johnson A.E., and Rosenblatt J.S. Haloperidol-induced disruption of retrieval behavior and reversal with apomorphine in lactating rats. Physiol Behav 48 (1990) 211-214
26. Hameleers R., Blokland A., Steinbusch H.W., Visser-Vandewalle V., and Temel Y. Hypomobility after DOI administration can be reversed by subthalamic nucleus deep brain stimulation. Behav Brain Res 185 (2007) 65-67
27. Hansen S. Maternal behavior of female rats with 6-OHDA lesions in the ventral striatum: characterization of the pup retrieval deficit. Physiol Behav 55 (1994) 615-620
28. Hansen S., Harthon C., Wallin E., Löfberg L., and Svensson K. Mesotelencephalic dopamine system and reproductive behavior in the female rat: effects of ventral tegmental 6-hydroxydopamine lesions on maternal and sexual responsiveness. Behav Neurosci 105 (1991) 588-598
29. Hansen S., Harthon C., Wallin E., Löfberg L., and Svensson K. The effects of 6-OHDA-induced dopamine depletions in the ventral or dorsal striatum on maternal and sexual behavior in the female rat. Pharmacol Biochem Behav 39 (1991) 71-77
30. Hansen S., Bergvall A.H., and Nyiredi S. Interaction with pups enhances dopamine release in the ventral striatum of maternal rats: a microdialysis study. Pharmacol Biochem Behav 45 (1993) 673-676
31. Ichikawa J., and Meltzer H.Y. DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Res 698 (1995) 204-208
32. Ichikawa J., Dai J., and Meltzer H.Y. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release. Brain Res 907 (2001) 151-155
33. Jakab R.L., and Goldman-Rakic P.S. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95 (1998) 735-740
34. Ji S.P., Zhang Y., Van Cleemput J., Jiang W., Liao M., Li L., et al. Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse. Nat Med 12 (2006) 324-329
35. Kapur S., and Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med 52 (2001) 503-517
36. Kapur S., and Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics: a new hypothesis. Am J Psychiatry 158 (2001) 360-369
37. Kebabian J.W., and Calne D.B. Multiple receptors for dopamine. Nature 277 (1979) 93-96
38. Keer S.E., and Stern J.M. Dopamine receptor blockade in the nucleus accumbens inhibits maternal retrieval and licking, but enhances nursing behavior in lactating rats. Physiol Behav 67 (1999) 659-669
39. Krebs-Thomson K., and Geyer M.A. The role of 5-HT(1A) receptors in the locomotor-suppressant effects of LSD: WAY-100635 studies of 8-OH-DPAT, DOI and LSD in rats. Behav Pharmacol 7 (1996) 551-559
40. Kuroki T., Meltzer H.Y., and Ichikawa J. 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res 972 (2003) 216-221
41. Lane R.F., Blaha C.D., and Rivet J.M. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry. Brain Res 460 (1988) 398-401
42. Lerch-Haner J.K., Frierson D., Crawford L.K., Beck S.G., and Deneris E.S. Serotonergic transcriptional programming determines maternal behavior and offspring survival. Nat Neurosci 11 (2008) 1001-1003
43. Li M., Davidson P., Budin R., Kapur S., and Fleming A.S. Effects of typical and atypical antipsychotic drugs on maternal behavior in postpartum female rats. Schizophr Res 70 (2004) 69-80
44. Li M., Budin R., Fleming A.S., and Kapur S. Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats. Psychopharmacology (Berl) 181 (2005) 600-610
45. Li M., Budin R., Fleming A.S., and Kapur S. Effects of chronic typical and atypical antipsychotic drug treatment on maternal behavior in rats. Schizophr Res 75 (2005) 325-336
46. Lieberman J.A., Kane J.M., and Johns C.A. Clozapine: guidelines for clinical management. J Clin Psychiatry 50 (1989) 329-338
47. Matsubara S., Matsubara R., Kusumi I., Koyama T., and Yamashita I. Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J Pharmacol Exp Ther 265 (1993) 498-508
48. Meltzer H.Y. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl) 99 Suppl (1989) S18-S27
49. Meltzer H.Y., Matsubara S., and Lee J.C. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull 25 (1989) 390-392
50. Meltzer H.Y., Matsubara S., and Lee J.C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251 (1989) 238-246
51. Meltzer H.Y., Li Z., Kaneda Y., and Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuro-psychopharmacol Biol Psychiatry 27 (2003) 1159-1172
52. Miller R.J., and Hiley C.R. Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism. Nature 248 (1974) 596-597
53. Miller S.M., and Lonstein J.S. Dopamine d1 and d2 receptor antagonism in the preoptic area produces different effects on maternal behavior in lactating rats. Behav Neurosci 119 (2005) 1072-1083
54. Mittman S.M., and Geyer M.A. Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol. Psychopharmacology (Berl) 105 (1991) 69-76
55. Miyamoto S., Duncan G.E., Marx C.E., and Lieberman J.A. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10 (2005) 79-104
56. Murray A.M., and Waddington J.L. The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices. Eur J Pharmacol 186 (1990) 79-86
57. Nocjar C., Roth B.L., and Pehek E.A. Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience 111 (2002) 163-176
58. Numan M. Motivational systems and the neural circuitry of maternal behavior in the rat. Dev Psychobiol 49 (2007) 12-21
59. Numan M., and Insel T.R. The neurobiology of parental behavior (2003), Springer, New York 236-237
60. Numan M., and Stolzenberg D.S. Medial preoptic area interactions with dopamine neural systems in the control of the onset and maintenance of maternal behavior in rats. Front Neuroendocrinol 30 (2009) 46-64
61. Numan M., Numan M.J., Pliakou N., Stolzenberg D.S., Mullins O.J., Murphy J.M., et al. The effects of D1 or D2 dopamine receptor antagonism in the medial preoptic area, ventral pallidum, or nucleus accumbens on the maternal retrieval response and other aspects of maternal behavior in rats. Behav Neurosci 119 (2005) 1588-1604
62. Olivier B., Mos J., van Oorschot R., and Hen R. Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 28 Suppl 2 (1995) 80-90
63. Parsons L.H., and Justice Jr. J.B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606 (1993) 195-199
64. Perry B.D., Simon P.R., and U'Prichard D.C. Interactions of neuroleptic compounds at alpha 2-adrenergic receptor affinity states in bovine caudate nucleus. Eur J Pharmacol 95 (1983) 315-318
65. Pompeiano M., Palacios J.M., and Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 23 (1994) 163-178
66. Remington G., and Kapur S. Atypical antipsychotics: are some more atypical than others?. Psychopharmacology (Berl) 148 (2000) 3-15
67. Rosenblatt J.S., and Lehrman D.S. Maternal behavior in the laboratory rat. In: Rheingold H.L. (Ed). Maternal behavior in mammals (1963), John Wiley and Sons, New York 8-57
68. Safferman A., Lieberman J.A., Kane J.M., Szymanski S., and Kinon B. Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 17 (1991) 247-261
69. Schmauss M., Wolff R., Erfurth A., and Rüther E. Tolerability of long term clozapine treatment. Psychopharmacology (Berl) 99 Suppl (1989) S105-S108
70. Seeman P. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7 (1992) 261-284
71. Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry 47 (2002) 27-38
72. Seeman P., Lee T., Chau-Wong M., and Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261 (1976) 717-719
73. Silva M.R., Bernardi M.M., and Felicio L.F. Effects of dopamine receptor antagonists on ongoing maternal behavior in rats. Pharmacol Biochem Behav 68 (2001) 461-468
74. Silva M.R., Bernardi M.M., Cruz-Casallas P.E., and Felicio L.F. Pimozide injections into the nucleus accumbens disrupt maternal behaviour in lactating rats. Pharmacol Toxicol 93 (2003) 42-47
75. Stern J.M., and Keer S.E. Maternal motivation of lactating rats is disrupted by low dosages of haloperidol. Behav Brain Res 99 (1999) 231-239
76. Stern J.M., and Taylor L.A. Haloperidol inhibits maternal retrieval and licking, but facilitates nursing behavior and milk ejection in lactating rats. J Neuroendocrinol 3 (1991) 591-596
77. Stolzenberg D.S., McKenna J.B., Keough S., Hancock R., Numan M.J., and Numan M. Dopamine D1 receptor stimulation of the nucleus accumbens or the medial preoptic area promotes the onset of maternal behavior in pregnancy-terminated rats. Behav Neurosci 121 (2007) 907-919
78. Veiga C.P., Miczek K.A., Lucion A.B., and Almeida R.M. Effect of 5-HT1B receptor agonists injected into the prefrontal cortex on maternal aggression in rats. Braz J Med Biol Res 40 (2007) 825-830
79. Whitaker N.G., and Lindstrom T.D. Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys. Drug Metab Dispos 15 (1987) 107-113
80. Wing L.L., Tapson G.S., and Geyer M.A. 5HT-2 mediation of acute behavioral effects of hallucinogens in rats. Psychopharmacology (Berl) 100 (1990) 417-425
81. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., and Jennes L. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351 (1995) 357-373
82. Zavitsanou K., Nguyen V.H., Han M., and Huang X.F. Effects of typical and atypical antipsychotic drugs on rat brain muscarinic receptors. Neurochem Res 32 (2007) 525-532
83. Zhao C., and Li M. Sedation and disruption of maternal motivation underlie the disruptive effects of antipsychotic treatment on rat maternal behavior. Pharmacol Biochem Behav 92 (2009) 147-156